US 11192958
Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
granted A61KA61K39/00A61K45/06
Quick answer
US patent 11192958 (Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease) held by The Board of Regents of the University of Texas System expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K39/00, A61K45/06, A61K47/6851, A61K47/6871